Liliana Rossetti

Dr. Liliana Rossetti


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
LRLiliana Rossetti
Liliana Rossetti
CRC. P. Radic
C. P. Radic
ILI. B. Larripa
I. B. Larripa
CBC. D. DE Brasi
C. D. DE Brasi

1 July 2005 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
LRLiliana Rossetti
Liliana Rossetti
CRClaudia Pamela Radic
Claudia Pamela Radic
ILIrene Beatriz Larripa
Irene Beatriz Larripa
CBCarlos Daniel De Brasi
Carlos Daniel De Brasi
Background: Factor VIII intron 22 inversions (Inv22) cause 40%–45% of severe cases of hemophilia A in all human populations. Currently, Inv22 can be analyzed either by Southern blotting or by rapid long-distance-PCR–based approaches. We describe an alternative method using inverse-PCR (I-PCR).

30 September 2004 in Human Mutation
Verified
Journal Article
Open access
PDF file
LRLiliana Rossetti
Liliana Rossetti
AGAnne Goodeve
Anne Goodeve
ILIrene B. Larripa
Irene B. Larripa
CBCarlos D. De Brasi
Carlos D. De Brasi
Although large deletions from the coagulation factor VIII gene, F8, are responsible for 5% of severe hemophilia A (seHA), few of them have been fully characterised. A detailed description of a large partial deletion of the F8 caused by unequal recombination between homeologous AluSx-derived sequences is presented. The proband, a case of isolated hemophilia A with a high inhibitor titre (5700 BU), showed a consistent absence of PCR-amplification of exons 4 to 10, EX4_EX10del. Two approaches were used to narrow down the deletion breakpoints: a direct physical analysis based on PCR (that additionally permits carrier detection in the family); and, under the hypothesis that the mutation resulted from homologous recombination, sequence alignments of F8 intron 3 and 10. Both approaches indicate an unequal crossing over (CO) between two Alu-related sequences. Both elements involved were derived from the AluSx-subfamily consensus and demonstrate 86% sequence identity (with only single-base mismatches), with three gaps (of 2, 3 and 14-bases) and two main tracts of perfectly homologous sequence (28 and 24-bp). The short stretch of intron 10 embedded into intron 3 sequence, linked to the CO, represents a typical hallmark of homologous recombination (double-strand break repair model). A detailed description of EX4_EX10del mutation is c.[338+3485delins1687+2223_1687+2225; 338+3551_1687+2291 del]. The common involvement of unequal homologous recombination mediated by repetitive elements allowed us to suggest that our experimental design (based on intron sequence alignments) may be successfully applied to rearrangements involved in other X-linked inherited diseases. Like other Alu-rich genes throughout the human genome, Alu-mediated homologous recombination in F8 may be an important cause of hemophilia by promoting large DNA deletions.

Verified
Journal Article
Open access
PDF file
LRLiliana Rossetti
Liliana Rossetti
CRClaudia P. Radic
Claudia P. Radic
MAMiguel M. Abelleyro
Miguel M. Abelleyro
ILIrene B. Larripa
Irene B. Larripa
CBCarlos D. De Brasi
Carlos D. De Brasi
The factor VIII gene (F8) intron 22 inversion (Inv22) is a paradigmatic duplicon-mediated rearrangement, found in about one half of patients with severe hemophilia A worldwide. The identification of this prevalent cause of hemophilia was delayed for nine years after the F8 characterization in 1984. The aim of this review is to present the wide diversity of practical approaches that have been developed for genotyping the Inv22 (and related int22h rearrangements) since discovery in 1993. The sequence—Southern blot, long distance-PCR and inverse shifting-PCR—for Inv22 genotyping is an interesting example of scientific ingenuity and evolution in order to resolve challenging molecular diagnostic problems.

1 June 2007 in Haematologica
Verified
Journal Article
Open access
PDF file
LRLiliana Rossetti
Liliana Rossetti
CRC. P. Radic
C. P. Radic
MCM. Candela
M. Candela
RBR. P. Bianco
R. P. Bianco
MPM. de Tezanos Pinto
M. de Tezanos Pinto
CBC. D. De Brasi
C. D. De Brasi
Hemophilia A (HA) is caused by heterogeneous mutations in the factor VIII gene (F8). This paper reports 16 novel small F8-mutations and rearrangements in a series of 80 Argentinian families with severe-HA. Using an updated scheme for F8-analysis, we found 37 F8-inversions (46%), 10 large deletions (13%), 13 small ins/del (16%), 7 nonsense (9%) and 8 missense mutations (10%), including 4 new ones (p.T233K, p.W1942R, p.L2297P and p.L2301S). The potential changes leading to severe-HA of these latter mutations were suggested by bioinformatics. The F8-mutation was characterised in 76 families (95%). They received genetic counselling and precise information about treatment design.

28 March 2013 in Haemophilia
Verified
Journal Article
Closed access
PDF file
LRLiliana Rossetti
Liliana Rossetti
ISI. Szurkalo
I. Szurkalo
CRC. P. Radic
C. P. Radic
MAM. M. Abelleyro
M. M. Abelleyro
LPL. Primiani
L. Primiani
CBC. D. De Brasi
C. D. De Brasi